Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney

Physiological Genomics

Volumn 40, Issue 3, 2010, Pages 158-166

  Dunbar, Donald R ^a   Khaled, Hiba ^a   Evans, Louise C ^a   Al Dujaili, Emad A S ^a   Mullins, Linda J ^a   Mullins, John J ^a   Kenyon, Christopher J ^a   Bailey, Matthew A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adrenocorticotropic hormone; Calcium; Gene expression; Renal function; Steroids

Indexed keywords

ALDOSTERONE; AQUAPORIN 4; CALCIUM; CORTICOTROPIN; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; DEOXYCORTICOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE; FK 506 BINDING PROTEIN; RENIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TETRACOSACTIDE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 5; VITAMIN D;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CALCIUM HOMEOSTASIS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIURESIS; ELECTROLYTE METABOLISM; FLUID BALANCE; GENE EXPRESSION; HEMATOCRIT; HYPERTENSION; KALIURESIS; KIDNEY FUNCTION; MALE; MICROARRAY ANALYSIS; MOUSE; NATRIURESIS; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PHOSPHATURIA; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STEROID URINE LEVEL; STEROIDOGENESIS; THYMUS; VITAMIN D METABOLISM; WEIGHT GAIN; XENOBIOTIC METABOLISM;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CALCIUM; GENE EXPRESSION; HORMONES; KIDNEY; MALE; MICE; MICE, INBRED C57BL; POTASSIUM; TRANSCRIPTION, GENETIC;

MUS;

EID: 76549118309     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00088.2009     Document Type: Article

References (49)

1. Al-Dujaili EA, Kenyon CJ, Mullins LJ, Mullins JJ. Development of highly sensitive and specific enzyme immunosorbent assays for deoxycorticosterone and corticosterone: application to urine samples from Cyp11b1 knockout mice (Abstract). Endocr Abstr 15: P301, 2008.
2. Al-Dujaili EA, Mullins LJ, Bailey MA, Kenyon CJ. Development of a highly sensitive ELISA for aldosterone in mouse urine: validation in physiological and pathophysiological states of aldosterone excess and depletion. Steroids 74: 456-462, 2008.
3. - cotransporter in renal proximal tubules. Kidney Int 57: 1063-1071, 2000.
4. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
5. Bailey MA, Cantone A, Yan Q, MacGregor GG, Leng Q, Amorim JB, Wang T, Hebert SC, Giebisch G, Malnic G. Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet. Kidney Int 70: 51-59, 2006.
6. Bailey MA, Mullins JJ, Kenyon CJ. Mineralocorticoid and glucocorticoid receptors stimulate epithelial sodium channel activity in a mouse model of Cushing syndrome. Hypertension 54: 890-896, 2009.
7. Bailey MA, Paterson JM, Hadoke PW, Wrobel N, Bellamy CO, Brownstein DG, Seckl JR, Mullins JJ. A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess. J Am Soc Nephrol 19: 47-58, 2008.
8. Borner USG, Bablok W, Busch EW. [A specific fully enzymatic method for creatinine: reference values in serum (author's translation)]. J Clin Chem Clin Biochem 17: 679-682, 1979.
9. Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank Products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92, 2004.
10. Castello R, Schwarting R, Muller C, Hierholzer K. Immunohistochemical localization of 11-hydroxysteroid dehydrogenase in rat kidney with monoclonal antibody. Renal Physiol Biochem 12: 320-327, 1989.
11. Cheng Q, Aleksunes LM, Manautou JE, Cherrington NJ, Scheffer GL, Yamasaki H, Slitt AL. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm 5: 77-91, 2008.
12. Chun RF, Adams JS, Hewison M. Back to the future: a new look at "old" vitamin D. J Endocrinol 198: 261-269, 2008.
13. Denny WB, Prapapanich V, Smith DF, Scammell JG. Structurefunction analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity. Endocrinology 146: 3194-3201, 2005.
14. Evans AL, Brown W, Kenyon CJ, Maxted KJ, Smith DC. Improved system for measuring systolic blood pressure in the conscious rat. Med Biol Eng Comput 32: 101-102, 1994.
15. Friedman PA, Gesek FA. Cellular calcium transport in renal epithelia: measurement, mechanisms, and regulation. Physiol Rev 75: 429-471, 1995.
16. Gaeggeler HP, Gonzalez-Rodriguez E, Jaeger NF, Loffing-Cueni D, Norregaard R, Loffing J, Horisberger JD, Rossier BC. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosteronestimulated sodium transport in a novel renal cell line. J Am Soc Nephrol 16: 878-891, 2005.
17. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315, 2004.
18. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80, 2004.
19. Gong R, Morris DJ, Brem AS. Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2. Life Sci 82: 631-637, 2008.
20. 3-responsive epithelia. J Biol Chem 274: 8375-8378, 1999.
21. Hus-Citharel A, Bouby N, Frugiere A, Bodineau L, Gasc JM, Llorens-Cortes C. Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int 74: 486-494, 2008.
22. Kenyon CJ, Brown WB, Fraser R, Tonolo G, McPherson F, Davies DL. Effects of dexamethasone on body fluid and electrolyte composition of rats. Acta Endocrinol (Copenh) 122: 599-604, 1990.
23. Kenyon CJ, Morton JJ. Experimental Steroid-Induced Hypertension. Oxford: Blackwell Scientific, 1994, p. 494-500.
24. Kenyon CJ, Saccoccio NA, Morris DJ. Glucocorticoid inhibition of mineralocorticoid action in the rat. Clin Sci (Lond) 67: 329-335, 1984.
25. Kotelevtsev Y, Brown RW, Fleming S, Kenyon C, Edwards CR, Seckl JR, Mullins JJ. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J Clin Invest 103: 683-689, 1999.
26. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum- and glucocorticoid- inducible kinase isoforms. Physiol Rev 86: 1151-1178, 2006.
27. Magiakou MA, Smyrnaki P, Chrousos GP. Hypertension in Cushing's syndrome. Best Pract Res Clin Endocrinol Metab 20: 467-482, 2006.
28. 2. Biochim Biophys Acta 1761: 221-234, 2006.
29. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85: 679-715, 2005.
30. Mensenkamp AR, Hoenderop JG, Bindels RJ. Recent advances in renal tubular calcium reabsorption. Curr Opin Nephrol Hypertens 15: 524-529, 2006.
31. Michailidou Z, Carter RN, Marshall E, Sutherland HG, Brownstein DG, Owen E, Cockett K, Kelly V, Ramage L, Al-Dujaili EA, Ross M, Maraki I, Newton K, Holmes MC, Seckl JR, Morton NM, Kenyon CJ, Chapman KE. Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptations to high-fat diet. FASEB J 22: 3896-3907, 2008.
32. Mullins LJ, Peter A, Wrobel N, McNeilly JR, McNeilly AS, Al-Dujaili EA, Brownstein DG, Mullins JJ, Kenyon CJ. Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. J Biol Chem 284: 3925-3934, 2009.
33. Nguyen Dinh Cat A, Ouvrard-Pascaud A, Tronche F, Clemessy M, Gonzalez-Nunez D, Farman N, Jaisser F. Conditional transgenic mice for studying the role of the glucocorticoid receptor in the renal collecting duct. Endocrinology 150: 2202-2210, 2008.
34. Oelkers W, Kohler A, Belkien L, Fuchs-Hammoser R, Maiga M, Scherer B, Weber PC. Studies on the mechanism by which ACTH stimulates renin activity and angiotensin II formation in man. Acta Endocrinol (Copenh) 100: 573-580, 1982.
35. Ogasawara M, Nomura K, Shibata N, Ujihara M, Kobayashi M, Demura H. Surgical stress increases renal glutathione content via increased glucocorticoid, and resistance to subsequent oxidative injury in the rat: significant link between endocrine response and cell defense system under the stress. Endocr J 46: 99-106, 1999.
36. Ong SL, Vickers JJ, Zhang Y, McKenzie KU, Walsh CE, Whitworth JA. Role of xanthine oxidase in dexamethasone-induced hypertension in rats. Clin Exp Pharmacol Physiol 34: 517-519, 2007.
37. Ortiz PA, Garvin JL. Intrarenal transport and vasoactive substances in hypertension. Hypertension 38: 621-624, 2001.
38. Pepin MC, Pothier F, Barden N. Impaired type II glucocorticoidreceptor function in mice bearing antisense RNA transgene. Nature 355: 725-728, 1992.
39. Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 88: 2384-2392, 2003.
40. 2+ handling in sgk1 knockout mice. Pflügers Arch 452: 444-452, 2006.
41. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: 3, 2004.
42. Tan SY, Mulrow PJ. The contribution of the zona fasciculata and glomerulosa to plasma 11-deoxycorticosterone levels in man. J Clin Endocrinol Metab 41: 126-130, 1975.
43. Verkman AS. Dissecting the roles of aquaporins in renal pathophysiology using transgenic mice. Semin Nephrol 28: 217-226, 2008.
44. White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11: 320 -327, 2000.
45. Whitworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 1: 291-299, 2005.
46. Williams GH. Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Fail Rev 10: 7-13, 2005.
47. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280: 4609-4616, 2005.
48. Yoshinari K, Takagi S, Sugatani J, Miwa M. Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db/db mice. Biol Pharm Bull 29: 1634-1638, 2006.
49. Zhang Y, Chan MM, Andrews MC, Mori TA, Croft KD, McKenzie KU, Schyvens CG, Whitworth JA. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens 18: 910-916, 2005.